Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Bariatric Surgery in Children. (BASIC)

25 augusti 2021 uppdaterad av: Maastricht University Medical Center

The BASIC Trial. Morbid Obesity in Children and Adolescents: a Prospective Randomised Trial of Conservative Treatment Versus Surgery

Rationale:

In the Western world overweight and obesity is an increasing problem both in adults and in children. In youth, it is associated with early death and a number of co-morbidities including metabolic and endocrine changes, increased inflammatory status, cardiovascular abnormalities, nonalcoholic fatty liver disease, and impaired quality of life.

The standard treatment for morbid obesity in children is by combined life style interventions. However, the medium and long term effects of dietetic interventions, behaviour therapy and medication is relatively poor. In adults bariatric surgery shows good results with up to 30% weight reduction in 3 years. The preliminary results in youth are similar, but surgery in this age group is relatively uncommon. In the Netherlands surgery in this age group is only allowed in clinical trials, until the benefits and risks have been established. (National Health Authorities)

Objective:

To determine if surgery gives a superior weight and body mass index (BMI) reduction than combined life style interventions in adolescents with morbid obesity and to assess its effect on obesity associated co-morbidity.

Study design:

Prospective randomised interventional study.

Study population:

Morbidly obese children, aged 14 - 16 years, with sex and age adjusted BMI >40 kg/m2 or >35 kg/m2 with co-morbidity.

Intervention:

Bariatric surgery by laparoscopic adjustable gastric band (LAGB) or combined life style interventions

Main study parameters/endpoints:

Primary endpoints: weight loss, loss of excess weight, loss of excess BMI. Secondary endpoints: Body composition, pubertal development, metabolic and endocrine changes, inflammatory status, cardiovascular abnormalities, non-alcoholic steatohepatitis, brain development, quality of life, and behaviour changes. The potential complications of surgery are monitored.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Faktisk)

60

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Limburg
      • Maastricht, Limburg, Nederländerna, 6202ZA
        • Maastricht University Medical Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

14 år till 16 år (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Aged 14 to 16
  • Age and sex adjusted BMI >40 kg/m2 or >35 kg/m2 with associated co-morbidity.

    * Associated co-morbidity includes: glucose intolerance, type 2 diabetes, hypertension, pseudotumor cerebri, acanthosis nigricans, obstructive sleep apnoea syndrome, depression, arthropathies, non-alcoholic steatohepatitis and dyslipidemia.

  • > 1 year multidisciplinary organized weight reducing attempts with less than 5% weight loss
  • Demonstrate decisional capacity

Exclusion Criteria:

  • Psychologically not suitable
  • Pre-menarche or bone age <15 years in boys
  • Obesity associated to other disorders such as hypothyroidism
  • Syndromal disorders such as Prader-Willi syndrome
  • Severe cardiorespiratory impairment (ASA class 3 or higher)
  • Insufficiently fluid in the Dutch language
  • Unwillingness to adhere to follow-up programmes

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Kontrollgrupp
Control group will receive standard therapy consisting of combined lifestyle interventions.
Experimentell: Laparoscopic adjustable gastric band
Laparoscopic gastric band placement. Combined lifestyle interventions will continue after surgery.
Control group will receive standard therapy consisting of combined lifestyle interventions.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Weight
Tidsram: 6 months
Weight loss, excess weight loss and loss of excess BMI.
6 months
Weight
Tidsram: 12 months
Weight loss, excess weight loss and loss of excess BMI.
12 months
Weight
Tidsram: 24 months
Weight loss, excess weight loss and loss of excess BMI.
24 months
Weight
Tidsram: 36 months
Weight loss, excess weight loss and loss of excess BMI.
36 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Body composition
Tidsram: 12 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
12 months
Pubertal development
Tidsram: 6 months
Follow-up of hormonal status and Tanner stages.
6 months
Metabolic and endocrine changes
Tidsram: 6 months
6 months
Inflammatory status
Tidsram: 6 months
Measurement of serum inflammatory markers.
6 months
Cardiovascular abnormalities
Tidsram: 6 months
6 months
Non-alcoholic fatty liver disease
Tidsram: 6 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
6 months
Quality of life changes
Tidsram: 6 months
6 months
Behaviour changes
Tidsram: 6 months
Measuring impulsivity and positive reward dominance with a computer task.
6 months
Operative complications
Tidsram: up to 36 months
Early and late complications are being monitored
up to 36 months
Effects on sleep architecture
Tidsram: 6 months
6 months
Brain development
Tidsram: 6 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
6 months
Body composition
Tidsram: 24 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
24 months
Body composition
Tidsram: 36 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
36 months
Pubertal development
Tidsram: 12 months
Follow-up of hormonal status and Tanner stages.
12 months
Pubertal development
Tidsram: 24 months
Follow-up of hormonal status and Tanner stages.
24 months
Pubertal development
Tidsram: 36 months
Follow-up of hormonal status and Tanner stages.
36 months
Metabolic and endocrine changes
Tidsram: 12 months
12 months
Metabolic and endocrine changes
Tidsram: 24 months
24 months
Metabolic and endocrine changes
Tidsram: 36 months
36 months
Inflammatory status
Tidsram: 12 months
Measurement of serum inflammatory markers.
12 months
Inflammatory status
Tidsram: 24 months
Measurement of serum inflammatory markers.
24 months
Inflammatory status
Tidsram: 36 months
Measurement of serum inflammatory markers.
36 months
Cardiovascular abnormalities
Tidsram: 12 months
12 months
Cardiovascular abnormalities
Tidsram: 24 months
24 months
Cardiovascular abnormalities
Tidsram: 36 months
36 months
Non-alcoholic fatty liver disease
Tidsram: 12 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
12 months
Non-alcoholic fatty liver disease
Tidsram: 24 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
24 months
Non-alcoholic fatty liver disease
Tidsram: 36 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
36 months
Quality of life changes
Tidsram: 12 months
12 months
Quality of life changes
Tidsram: 24 months
24 months
Quality of life changes
Tidsram: 36 months
36 months
Effects on sleep architecture
Tidsram: 12 months
12 months
Effects on sleep architecture
Tidsram: 24 months
24 months
Effects on sleep architecture
Tidsram: 36 months
36 months
Behaviour changes
Tidsram: 12 months
Measuring impulsivity and positive reward dominance with a computer task.
12 months
Behaviour changes
Tidsram: 24 months
Measuring impulsivity and positive reward dominance with a computer task.
24 months
Behaviour changes
Tidsram: 36 months
Measuring impulsivity and positive reward dominance with a computer task.
36 months
Brain development
Tidsram: 12 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
12 months
Brain development
Tidsram: 24 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
24 months
Brain development
Tidsram: 36 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
36 months
Physical activity
Tidsram: 6 months
Assessment of physical activity using a questionnaire and an accelerometer.
6 months
Physical activity
Tidsram: 12 months
Assessment of physical activity using a questionnaire and an accelerometer.
12 months
Physical activity
Tidsram: 24
Assessment of physical activity using a questionnaire and an accelerometer.
24
Physical activity
Tidsram: 36 months
Assessment of physical activity using a questionnaire and an accelerometer.
36 months
Behavior towards food
Tidsram: 6 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
6 months
Behavior towards food
Tidsram: 12 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
12 months
Behavior towards food
Tidsram: 24 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
24 months
Behavior towards food
Tidsram: 36 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
36 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: LWE van Heurn, Professor, Maastricht University Medical Center
  • Huvudutredare: Yvonne Roebroek, PhD Student, Maastricht University Medical Center
  • Huvudutredare: Givan F Paulus, PhD Student, Spaarne Gasthuis, Haarlem

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 december 2011

Primärt slutförande (Förväntat)

1 december 2022

Avslutad studie (Förväntat)

1 december 2022

Studieregistreringsdatum

Först inskickad

22 juli 2010

Först inskickad som uppfyllde QC-kriterierna

29 juli 2010

Första postat (Uppskatta)

30 juli 2010

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

26 augusti 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

25 augusti 2021

Senast verifierad

1 augusti 2021

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • NL26279.068.09

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera